The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane
- PMID: 34196428
- DOI: 10.1096/fj.202100303R
The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane
Abstract
The sodium/iodide symporter (NIS) expresses at the basolateral plasma membrane of the thyroid follicular cell and mediates iodide accumulation required for normal thyroid hormonogenesis. Loss-of-function NIS variants cause congenital hypothyroidism due to impaired iodide accumulation in thyroid follicular cells underscoring the significance of NIS for thyroid physiology. Here we report novel findings derived from the thorough characterization of the nonsense NIS mutant p.R636* NIS-leading to a truncated protein missing the last eight amino acids-identified in twins with congenital hypothyroidism. R636* NIS is severely mislocalized into intracellular vesicular compartments due to the lack of a conserved carboxy-terminal type 1 PDZ-binding motif. As a result, R636* NIS is barely targeted to the plasma membrane and therefore iodide transport is reduced. Deletion of the PDZ-binding motif causes NIS accumulation into late endosomes and lysosomes. Using PDZ domain arrays, we revealed that the PDZ-domain containing protein SCRIB binds to the carboxy-terminus of NIS by a PDZ-PDZ interaction. Furthermore, in CRISPR/Cas9-based SCRIB deficient cells, NIS expression at the basolateral plasma membrane is compromised, leading to NIS localization into intracellular vesicular compartments. We conclude that the PDZ-binding motif is a plasma membrane retention signal that participates in the polarized expression of NIS by selectively interacting with the PDZ-domain containing protein SCRIB, thus retaining the transporter at the basolateral plasma membrane. Our data provide insights into the molecular mechanisms that regulate NIS expression at the plasma membrane, a topic of great interest in the thyroid cancer field considering the relevance of NIS-mediated radioactive iodide therapy for differentiated thyroid carcinoma.
Keywords: PDZ domain-containing protein SCRIB; PDZ-binding motif; dyshormonogenic congenital hypothyroidism; iodide transport defect; sodium/iodide symporter (NIS).
© 2021 Federation of American Societies for Experimental Biology.
References
REFERENCES
-
- Nicola JP, Carrasco N, Amzel LM. Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter. Nat Commun. 2014;5:3948.
-
- De la Vieja A, Riesco-Eizaguirre G. Radio-Iodide treatment: from molecular aspects to the clinical view. Cancers (Basel). 2021;13:995.
-
- Martín M, Geysels RC, Peyret V, Bernal Barquero CE, Masini-Repiso AM, Nicola JP. Implications of Na+/I- symporter transport to the plasma membrane for thyroid hormonogenesis and radioiodide therapy. J Endoc Soc. 2019;3:222-234.
-
- Ravera S, Reyna-Neyra A, Ferrandino G, Amzel LM, Carrasco N. The Sodium/Iodide Symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol. 2017;79:261-289.
-
- Martín M, Modenutti CP, Gil Rosas ML, et al. A Novel SLC5A5 variant reveals the crucial role of kinesin light chain 2 in thyroid hormonogenesis. J Clin Endocrinol Metab. 2021. https://doi.org/10.1210/clinem/dgab283
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials